6351 - 6400 of 7916 Results
Title
Year
-
OPENTitle: Development of Chemical Probes for Investigation of Salt-Inducible Kinase Function in VivoJournal Name: ACS Chemical BiologyPublisher: American Chemical Society (ACS)Vol: 11Issue #: 8Start Page: 2105End Page: 2111Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1021/acschembio.6b00217Best OA location URL: https://europepmc.org/articles/pmc4992440?pdf=renderCitation Count: 60
- Upregulation of Glutaredoxin-1 Activates Microglia and Promotes Neurodegeneration: Implications for Parkinson's Disease2016OPENTitle: Upregulation of Glutaredoxin-1 Activates Microglia and Promotes Neurodegeneration: Implications for Parkinson's DiseaseJournal Name: Antioxidants & Redox SignalingPublisher: Mary Ann Liebert IncVol: 25Issue #: 18Start Page: 967End Page: 982Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1089/ars.2015.6598Best OA location URL: https://www.liebertpub.com/doi/pdf/10.1089/ars.2015.6598Citation Count: 38
-
RESTRICTEDTitle: Vagal neurocircuitry and its influence on gastric motilityJournal Name: Nature Reviews Gastroenterology & HepatologyPublisher: Springer Science and Business Media LLCVol: 13Issue #: 7Start Page: 389End Page: 401Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1038/nrgastro.2016.76Best OA location URL: https://europepmc.org/articles/pmc5605144?pdf=renderCitation Count: 201
-
OPENTitle: Inflammatory profile in LRRK2-associated prodromal and clinical PDJournal Name: Journal of NeuroinflammationPublisher: Springer Science and Business Media LLCVol: 13Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s12974-016-0588-5Best OA location URL: https://jneuroinflammation.biomedcentral.com/track/pdf/10.1186/s12974-016-0588-5Citation Count: 65
- A Phase 2A Trial of the Novel mGluR5-Negative Allosteric Modulator Dipraglurant for Levodopa-Induced Dyskinesia in Parkinson's Disease2016RESTRICTEDTitle: A Phase 2A Trial of the Novel mGluR5-Negative Allosteric Modulator Dipraglurant for Levodopa-Induced Dyskinesia in Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 31Issue #: 9Start Page: 1373End Page: 1380Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.26659Citation Count: 118
-
OPENTitle: Cautionary optimism: caffeine and Parkinson’s disease riskJournal Name: Journal of Clinical Movement DisordersPublisher: Springer Science and Business Media LLCVol: 3Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s40734-016-0037-8Best OA location URL: https://clinicalmovementdisorders.biomedcentral.com/track/pdf/10.1186/s40734-016-0037-8Citation Count: 5
-
OPENTitle: LRRK2 Regulates Voltage-Gated Calcium Channel FunctionJournal Name: Frontiers in Molecular NeurosciencePublisher: Frontiers Media SAVol: 9Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnmol.2016.00035Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnmol.2016.00035/pdfCitation Count: 47
- Objective characterization of daily living transitions in patients with Parkinson’s disease using a single body-fixed sensor2016RESTRICTEDTitle: Objective characterization of daily living transitions in patients with Parkinson’s disease using a single body-fixed sensorJournal Name: Journal of NeurologyPublisher: Springer Science and Business Media LLCVol: 263Issue #: 8Start Page: 1544End Page: 1551Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s00415-016-8164-6Citation Count: 43
- Pharmacologically distinct pramipexole-mediated akinesia vs. risk-taking in a rat model of Parkinson's disease2016OPENTitle: Pharmacologically distinct pramipexole-mediated akinesia vs. risk-taking in a rat model of Parkinson's diseaseJournal Name: Progress in Neuro-Psychopharmacology and Biological PsychiatryPublisher: Elsevier BVVol: 70Issue #:Start Page: 77End Page: 84Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.pnpbp.2016.05.004Best OA location URL: https://europepmc.org/articles/pmc5410378?pdf=renderCitation Count: 25
- Parkinson's disease-related network topographies characterized with resting state functional MRI2016OPENTitle: Parkinson's disease-related network topographies characterized with resting state functional MRIJournal Name: Human Brain MappingPublisher: WileyVol: 38Issue #: 2Start Page: 617End Page: 630Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/hbm.23260Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5118197Citation Count: 66
-
OPENTitle: Central Hypoventilation in Progressive Supranuclear PalsyJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 4Issue #: 1Start Page: 42End Page: 45Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mdc3.12348Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.12348Citation Count: 5
- Pure Autonomic Failure Versus Prodromal Dysautonomia in Parkinson's Disease: Insights from the Bedside2016OPENTitle: Pure Autonomic Failure Versus Prodromal Dysautonomia in Parkinson's Disease: Insights from the BedsideJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 4Issue #: 1Start Page: 141End Page: 144Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mdc3.12360Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.12360Citation Count: 11
- Dentate nucleus iron deposition is a potential biomarker for tremor‐dominant Parkinson's disease2016OPENTitle: Dentate nucleus iron deposition is a potential biomarker for tremor‐dominant Parkinson's diseaseJournal Name: NMR in BiomedicinePublisher: WileyVol: 30Issue #: 4Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/nbm.3554Best OA location URL: https://europepmc.org/articles/pmc4906439?pdf=renderCitation Count: 49
-
OPENTitle: Predictors of time to initiation of symptomatic therapy in early Parkinson's diseaseJournal Name: Annals of Clinical and Translational NeurologyPublisher: WileyVol: 3Issue #: 7Start Page: 482End Page: 494Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/acn3.317Best OA location URL: https://doi.org/10.1002/acn3.317Citation Count: 25
-
OPENTitle: Neurogenesis in Cancun: where science meets the seaJournal Name: DevelopmentPublisher: The Company of BiologistsVol: 143Issue #: 10Start Page: 1649End Page: 1654Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1242/dev.138412Best OA location URL: https://dev.biologists.org/content/develop/143/10/1649.full.pdfCitation Count: 0
-
RESTRICTEDTitle: Asparagine endopeptidase is an innovative therapeutic target for neurodegenerative diseasesJournal Name: Expert Opinion on Therapeutic TargetsPublisher: Informa UK LimitedVol: 20Issue #: 10Start Page: 1237End Page: 1245Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1080/14728222.2016.1182990Best OA location URL: https://europepmc.org/articles/pmc5315368?pdf=renderCitation Count: 42
-
OPENTitle: Analysis of Mitochondrial haemoglobin in Parkinson's disease brainJournal Name: MitochondrionPublisher: Elsevier BVVol: 29Issue #:Start Page: 45End Page: 52Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.mito.2016.05.001Best OA location URL: https://doi.org/10.1016/j.mito.2016.05.001Citation Count: 24
- Enabling breakthroughs in Parkinson’s disease with wearable technologies and big data analytics2016OPENTitle: Enabling breakthroughs in Parkinson’s disease with wearable technologies and big data analyticsJournal Name: mHealthPublisher: AME Publishing CompanyVol: 2Issue #:Start Page: 20End Page: 20Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.21037/mhealth.2016.04.02Best OA location URL: https://europepmc.org/articles/pmc5344108?pdf=renderCitation Count: 31
- LRRK2 phosphorylation level correlates with abnormal motor behaviour in an experimental model of levodopa-induced dyskinesias2016OPENTitle: LRRK2 phosphorylation level correlates with abnormal motor behaviour in an experimental model of levodopa-induced dyskinesiasJournal Name: Molecular BrainPublisher: Springer Science and Business Media LLCVol: 9Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13041-016-0234-2Best OA location URL: https://molecularbrain.biomedcentral.com/track/pdf/10.1186/s13041-016-0234-2Citation Count: 11
-
OPENTitle: Normative data for subcortical regional volumes over the lifetime of the adult human brainJournal Name: NeuroImagePublisher: Elsevier BVVol: 137Issue #:Start Page: 9End Page: 20Publication Date:Open Access(OA) Status: OPENLicense: publisher-specific-oaDOI - Digital Object Identifier: 10.1016/j.neuroimage.2016.05.016Best OA location URL: http://adni.loni.usc.edu/wp-content/uploads/how_to_apply/ADNI_Acknowledgement_List.pdfCitation Count: 114
-
OPENTitle: Analysis of DNAJC13 mutations in French-Canadian/French cohort of Parkinson's diseaseJournal Name: Neurobiology of AgingPublisher: Elsevier BVVol: 45Issue #:Start Page: 212.e13End Page: 212.e17Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2016.04.023Best OA location URL: http://hdl.handle.net/20.500.11794/13593Citation Count: 47
- How can rAAV‐α‐synuclein and the fibril α‐synuclein models advance our understanding of Parkinson's disease?2016RESTRICTEDTitle: How can rAAV‐α‐synuclein and the fibril α‐synuclein models advance our understanding of Parkinson's disease?Journal Name: Journal of NeurochemistryPublisher: WileyVol: 139Issue #: S1Start Page: 131End Page: 155Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1111/jnc.13627Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/jnc.13627Citation Count: 81
- Heterogeneity of Treatment Response to Citalopram for Patients With Alzheimer’s Disease With Aggression or Agitation: The CitAD Randomized Clinical Trial2016OPENTitle: Heterogeneity of Treatment Response to Citalopram for Patients With Alzheimer’s Disease With Aggression or Agitation: The CitAD Randomized Clinical TrialJournal Name: American Journal of PsychiatryPublisher: American Psychiatric Association PublishingVol: 173Issue #: 5Start Page: 465End Page: 472Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1176/appi.ajp.2015.15050648Best OA location URL: https://ajp.psychiatryonline.org/doi/pdf/10.1176/appi.ajp.2015.15050648Citation Count: 82
- The glucagon-like peptide 1 (GLP) receptor as a therapeutic target in Parkinson's disease: mechanisms of action2016RESTRICTEDTitle: The glucagon-like peptide 1 (GLP) receptor as a therapeutic target in Parkinson's disease: mechanisms of actionJournal Name: Drug Discovery TodayPublisher: Elsevier BVVol: 21Issue #: 5Start Page: 802End Page: 818Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.drudis.2016.01.013Best OA location URL: https://doi.org/10.1016/j.drudis.2016.01.013Citation Count: 246
- Transplantable living scaffolds comprised of micro-tissue engineered aligned astrocyte networks to facilitate central nervous system regeneration2016OPENTitle: Transplantable living scaffolds comprised of micro-tissue engineered aligned astrocyte networks to facilitate central nervous system regenerationJournal Name: Acta BiomaterialiaPublisher: Elsevier BVVol: 38Issue #:Start Page: 44End Page: 58Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.actbio.2016.04.021Best OA location URL: https://europepmc.org/articles/pmc5457669?pdf=renderCitation Count: 75
- Discovery of 3-aminopicolinamides as metabotropic glutamate receptor subtype 4 (mGlu4) positive allosteric modulator warheads engendering CNS exposure and in vivo efficacy2016OPENTitle: Discovery of 3-aminopicolinamides as metabotropic glutamate receptor subtype 4 (mGlu4) positive allosteric modulator warheads engendering CNS exposure and in vivo efficacyJournal Name: Bioorganic & Medicinal Chemistry LettersPublisher: Elsevier BVVol: 26Issue #: 12Start Page: 2915End Page: 2919Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.bmcl.2016.04.041Best OA location URL: https://europepmc.org/articles/pmc4899947?pdf=renderCitation Count: 3
-
RESTRICTEDTitle: How stable are Parkinson's disease subtypes in de novo patients: Analysis of the PPMI cohort?Journal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 28Issue #:Start Page: 62End Page: 67Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2016.04.027Citation Count: 147
-
OPENTitle: Morphological Alterations in the Thalamus, Striatum, and Pallidum in Autism Spectrum DisorderJournal Name: NeuropsychopharmacologyPublisher: Springer Science and Business Media LLCVol: 41Issue #: 11Start Page: 2627End Page: 2637Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1038/npp.2016.64Best OA location URL: https://www.nature.com/articles/npp201664.pdfCitation Count: 129
-
RESTRICTEDTitle: Technology in Parkinson's disease: Challenges and opportunitiesJournal Name: Movement DisordersPublisher: WileyVol: 31Issue #: 9Start Page: 1272End Page: 1282Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.26642Best OA location URL: http://minerva-access.unimelb.edu.au/bitstreams/9b88ef9a-46cf-56a6-adcc-40327184fd3c/downloadCitation Count: 477
- shRNA-Based Screen Identifies Endocytic Recycling Pathway Components That Act as Genetic Modifiers of Alpha-Synuclein Aggregation, Secretion and Toxicity2016OPENTitle: shRNA-Based Screen Identifies Endocytic Recycling Pathway Components That Act as Genetic Modifiers of Alpha-Synuclein Aggregation, Secretion and ToxicityJournal Name: PLOS GeneticsPublisher: Public Library of Science (PLoS)Vol: 12Issue #: 4Start Page: e1005995End Page: e1005995Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1371/journal.pgen.1005995Best OA location URL: https://journals.plos.org/plosgenetics/article/file?id=10.1371/journal.pgen.1005995&type=printableCitation Count: 76
- A First Tetraplex Assay for the Simultaneous Quantification of Total α-Synuclein, Tau, β-Amyloid42 and DJ-1 in Human Cerebrospinal Fluid2016OPENTitle: A First Tetraplex Assay for the Simultaneous Quantification of Total α-Synuclein, Tau, β-Amyloid42 and DJ-1 in Human Cerebrospinal FluidJournal Name: PLOS ONEPublisher: Public Library of Science (PLoS)Vol: 11Issue #: 4Start Page: e0153564End Page: e0153564Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1371/journal.pone.0153564Best OA location URL: https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0153564&type=printableCitation Count: 5
- The BioFIND study: Characteristics of a clinically typical Parkinson's disease biomarker cohort2016OPENTitle: The BioFIND study: Characteristics of a clinically typical Parkinson's disease biomarker cohortJournal Name: Movement DisordersPublisher: WileyVol: 31Issue #: 6Start Page: 924End Page: 932Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.26613Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.26613Citation Count: 51
- Free‐water and BOLD imaging changes in Parkinson's disease patients chronically treated with a MAO‐B inhibitor2016OPENTitle: Free‐water and BOLD imaging changes in Parkinson's disease patients chronically treated with a MAO‐B inhibitorJournal Name: Human Brain MappingPublisher: WileyVol: 37Issue #: 8Start Page: 2894End Page: 2903Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/hbm.23213Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4945383Citation Count: 34
-
RESTRICTEDTitle: Motor and nonmotor heterogeneity of LRRK2‐related and idiopathic Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 31Issue #: 8Start Page: 1192End Page: 1202Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.26614Citation Count: 100
- Resequencing analysis of five Mendelian genes and the top genes from genome-wide association studies in Parkinson’s Disease2016OPENTitle: Resequencing analysis of five Mendelian genes and the top genes from genome-wide association studies in Parkinson’s DiseaseJournal Name: Molecular NeurodegenerationPublisher: Springer Science and Business Media LLCVol: 11Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13024-016-0097-0Best OA location URL: https://molecularneurodegeneration.biomedcentral.com/track/pdf/10.1186/s13024-016-0097-0Citation Count: 61
-
OPENTitle: α‐synuclein genetic variability: A biomarker for dementia in Parkinson diseaseJournal Name: Annals of NeurologyPublisher: WileyVol: 79Issue #: 6Start Page: 991End Page: 999Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/ana.24664Best OA location URL: http://spiral.imperial.ac.uk/bitstream/10044/1/61098/6/Guella_et%20al_2018%2bSuppl.pdfCitation Count: 88
- A multivariate nonlinear mixed effects model for longitudinal image analysis: Application to amyloid imaging2016OPENTitle: A multivariate nonlinear mixed effects model for longitudinal image analysis: Application to amyloid imagingJournal Name: NeuroImagePublisher: Elsevier BVVol: 134Issue #:Start Page: 658End Page: 670Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neuroimage.2016.04.001Best OA location URL: https://europepmc.org/articles/pmc4912927?pdf=renderCitation Count: 83
- Characterization of RNA isolated from eighteen different human tissues: results from a rapid human autopsy program2016OPENTitle: Characterization of RNA isolated from eighteen different human tissues: results from a rapid human autopsy programJournal Name: Cell and Tissue BankingPublisher: Springer Science and Business Media LLCVol: 17Issue #: 3Start Page: 361End Page: 375Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s10561-016-9555-8Best OA location URL: https://europepmc.org/articles/pmc5026224?pdf=renderCitation Count: 63
- Executive functioning and risk-taking behavior in Parkinson’s disease patients with impulse control disorders2016OPENTitle: Executive functioning and risk-taking behavior in Parkinson’s disease patients with impulse control disordersJournal Name: Journal of Neural TransmissionPublisher: Springer Science and Business Media LLCVol: 123Issue #: 6Start Page: 573End Page: 581Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s00702-016-1549-yBest OA location URL: https://hal.sorbonne-universite.fr/hal-01311564/file/Pineau_2016_Executive.pdfCitation Count: 15
-
RESTRICTEDTitle: MRI biomarkers — a precision medicine tool in neurology?Journal Name: Nature Reviews NeurologyPublisher: Springer Science and Business Media LLCVol: 12Issue #: 6Start Page: 323End Page: 324Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1038/nrneurol.2016.51Best OA location URL: https://europepmc.org/articles/pmc5512159?pdf=renderCitation Count: 8
-
OPENTitle: Clinical-genetic model predicts incident impulse control disorders in Parkinson's diseaseJournal Name: Journal of Neurology, Neurosurgery & PsychiatryPublisher: BMJVol: 87Issue #: 10Start Page: 1106End Page: 1111Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1136/jnnp-2015-312848Best OA location URL: https://europepmc.org/articles/pmc5098340?pdf=renderCitation Count: 101
- Discovery, Synthesis, and Preclinical Characterization of N-(3-Chloro-4-fluorophenyl)-1H-pyrazolo[4,3-b]pyridin-3-amine (VU0418506), a Novel Positive Allosteric Modulator of the Metabotropic Glutamate Receptor 4 (mGlu4)2016OPENTitle: Discovery, Synthesis, and Preclinical Characterization of N-(3-Chloro-4-fluorophenyl)-1H-pyrazolo[4,3-b]pyridin-3-amine (VU0418506), a Novel Positive Allosteric Modulator of the Metabotropic Glutamate Receptor 4 (mGlu4)Journal Name: ACS Chemical NeurosciencePublisher: American Chemical Society (ACS)Vol: 7Issue #: 9Start Page: 1192End Page: 1200Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1021/acschemneuro.6b00035Best OA location URL: https://europepmc.org/articles/pmc5031509?pdf=renderCitation Count: 41
-
OPENTitle: Plasma neuronal exosomal levels of Alzheimer's disease biomarkers in normal agingJournal Name: Annals of Clinical and Translational NeurologyPublisher: WileyVol: 3Issue #: 5Start Page: 399End Page: 403Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/acn3.309Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/acn3.309Citation Count: 60
-
OPENTitle: Mild cognitive impairment in Parkinson's disease versus Alzheimer's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 27Issue #:Start Page: 54End Page: 60Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2016.04.007Best OA location URL: https://europepmc.org/articles/pmc4887313?pdf=renderCitation Count: 25
- Cortical phosphorylated α-Synuclein levels correlate with brain wave spectra in Parkinson's disease2016OPENTitle: Cortical phosphorylated α-Synuclein levels correlate with brain wave spectra in Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 31Issue #: 7Start Page: 1012End Page: 1019Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.26621Best OA location URL: https://europepmc.org/articles/pmc4931950?pdf=renderCitation Count: 31
- Gene Prioritization for Imaging Genetics Studies Using Gene Ontology and a Stratified False Discovery Rate Approach2016OPENTitle: Gene Prioritization for Imaging Genetics Studies Using Gene Ontology and a Stratified False Discovery Rate ApproachJournal Name: Frontiers in NeuroinformaticsPublisher: Frontiers Media SAVol: 10Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fninf.2016.00014Best OA location URL: https://www.frontiersin.org/articles/10.3389/fninf.2016.00014/pdfCitation Count: 8
- α-Synuclein vaccination modulates regulatory T cell activation and microglia in the absence of brain pathology2016OPENTitle: α-Synuclein vaccination modulates regulatory T cell activation and microglia in the absence of brain pathologyJournal Name: Journal of NeuroinflammationPublisher: Springer Science and Business Media LLCVol: 13Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s12974-016-0532-8Best OA location URL: https://jneuroinflammation.biomedcentral.com/track/pdf/10.1186/s12974-016-0532-8Citation Count: 33
-
OPENTitle: Personality and reported quality of life in Parkinson's diseaseJournal Name: International Journal of Geriatric PsychiatryPublisher: WileyVol: 32Issue #: 3Start Page: 324End Page: 330Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/gps.4475Best OA location URL: https://europepmc.org/articles/pmc5333497?pdf=renderCitation Count: 21
- Benzoyl chloride derivatization with liquid chromatography–mass spectrometry for targeted metabolomics of neurochemicals in biological samples2016OPENTitle: Benzoyl chloride derivatization with liquid chromatography–mass spectrometry for targeted metabolomics of neurochemicals in biological samplesJournal Name: Journal of Chromatography APublisher: Elsevier BVVol: 1446Issue #:Start Page: 78End Page: 90Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.chroma.2016.04.006Best OA location URL: https://europepmc.org/articles/pmc4845038?pdf=renderCitation Count: 217
- Evaluation of alpha-synuclein immunohistochemical methods for the detection of Lewy-type synucleinopathy in gastrointestinal biopsies2016OPENTitle: Evaluation of alpha-synuclein immunohistochemical methods for the detection of Lewy-type synucleinopathy in gastrointestinal biopsiesJournal Name: Acta Neuropathologica CommunicationsPublisher: Springer Science and Business Media LLCVol: 4Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s40478-016-0305-8Best OA location URL: https://actaneurocomms.biomedcentral.com/track/pdf/10.1186/s40478-016-0305-8Citation Count: 65